期刊文献+

不同类型冠心病患者血清炎症因子的水平对比 被引量:12

A comparative study on serum levels of inflammatory factors in patients with different types of coronary heart diseases
下载PDF
导出
摘要 目的了解不同类型冠心病患者血清炎症因子的水平,探讨炎症因子在冠心病发生、发展中的作用及临床意义。方法检测急性心肌梗死组(AMI)、不稳定型心绞痛组(UAP)、稳定型心绞痛组(SAP)、无冠心病者(对照组)的血清高敏C反应蛋白(hs-CRP)、基质金属蛋白酶-9(MMP-9)、可溶性白细胞分化抗原40配体(sCD40L)的水平并进行统计学比较。结果与对照组比较,AMI、UAP组的血清炎症因子的水平均明显增高(P<0.05);与SAP组比较,AMI、UAP组的血清炎症因子的水平均明显增高(P<0.05);与UAP组比较,AMI组的血清炎症因子的水平均明显增高(P<0.05)。结论 hs-CRP、MMP-9、sCD40L均参与了冠状动脉粥样硬化的发生与发展,而且这些血清炎症因子的水平高低与冠心病的严重程度相关。 Objective To compare serum levels of inflammatory factors in patients with different types of coronary heart diseases, and to study the role of inflammatory factors in development of coronary heart diseases. Methods Serum levels of high - sensitivity C - reactive protein, matrix metalloproteinase-9 (MMP- 9 ), soluble CD40 ligand in patients with acute myocardial infarction (AMI), unstable angina pectoris (UAP), stable angina pectoris(SAP) and control group(CG) were determined and statistically analyzed. Results Serum levels of inflammatory factors in patients with AMI and UAP were obviously higher than those of patients in SAP group and control group ( P 〈 0.05 ). Serum levels of inflammatory factors in patients with AMI were obviously higher than those of patients with UAP( P 〈 0.05 ). Conclusion Serum levels of Hs - CRP, MMP -9 and sCD40L are all participated in the development of coronary heart diseases, and serum levels of inflammatory factors are correla- ted with the severity of coronary heart diseases.
出处 《临床和实验医学杂志》 2012年第15期1180-1181,共2页 Journal of Clinical and Experimental Medicine
关键词 冠心病 高敏C反应蛋白 基质金属蛋白酶-9 可溶性白细胞分化抗原40配体 Coronary heart disease High- sensitivity C -reactive protein Matrix metalloproteinane- 9 Soluble CD40 ligand
  • 相关文献

参考文献11

  • 1Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coro- nary syndromes : acute coronary syndromes without persistent ST segment elevation ; recommendations of the Task Force of the European Society of Cardiology [ J ]. Eur Heart J, 2000,21 (17) : 1406 - 1432. 被引量:1
  • 2Libby P. Inflammation in athemsclemsis [ J ]. Nature, 2002,420 (6917) :868 - 874. 被引量:1
  • 3Hackam DG, Anand SS. Emerging risk factors for atherosclemtic vascu- lar disease: a critical review of the evidence [ J ]. JAMA, 2003,290 (7) :932 -940. 被引量:1
  • 4高颖,蔡定芳.基质金属蛋白酶-9与炎症反应研究进展[J].中国病理生理杂志,2003,19(8):1133-1136. 被引量:33
  • 5张园园,张运,张梅,高月花,李秀昌,方永奇.辛伐他汀、丙丁酚和卡托普利在动脉粥样硬化斑块消退中的作用及与金属蛋白酶1和组织抑制物1基因表达的关系[J].中国动脉硬化杂志,2003,11(5):401-404. 被引量:43
  • 6Nomoto K, Oguehi S, Watanabe I, et al. Involvement of inflammation in acute coronary syndromes assessed by levels of high - sensitivity C - reactive protein, matrix metalloproteinase -9 and seluble vascular- cell adhesion molecule- I [ J]. J Cardiol, 2003,42 (5) :201 -206. 被引量:1
  • 7Zeng B, Prasan A, Fung KC, et al. Elevated circulating levels of matrix metalloproteinase -9 and -2 in patients with symptomatic coronary ar- tery disease[J]. Intern Med J, 2005,35(6) :331 -335. 被引量:1
  • 8Blankenberg S, Rupprecht HI, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of pa- tients with cardiovascular disease [ J]. Circulation, 2003,107 ( 12 ) : 1579 - 1585. 被引量:1
  • 9Henn V, Steinbach S, BUchner K, et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is tempo- rally limited by coexpressed CD40 [ J]. Blood, 2001,98 (4) : 1047 - 1054. 被引量:1
  • 10Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syn- dromes express enhanced CIM0 ligand/CD154 on platelets[ J]. Heart, 2001,86(6) :649 -655. 被引量:1

二级参考文献33

  • 1Ghislain Opdenakker, Philippe E. Van den Steen, Benedicte Dubois, et al. Gelatinase B functions as regulator and effector in leukocyte biology[J]. J Leukoc Biol, 2001, 69(6) : 851 -859. 被引量:1
  • 2Rosenberg GA, Lee Anna Cunningham, James Wallace, et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP - 9 linked to stromelysin- 1 and microglia in cells cultures[J]. Brain Res,2001, 893(1 - 2) : 104 - 112. 被引量:1
  • 3Lijnen HR, Silence J, Van Hoef, et al. Stromelysin- 1(MMP- 3) - independent gelatinase expression and activaton in mice[J]. Blood, 1998, 91(6): 2045- 2053. 被引量:1
  • 4Miyajina S, Akaike T, Matsumoto K, et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro[J]. Microb Pathog, 2001, 31(6) : 271 - 281. 被引量:1
  • 5Li DQ, kokeshwar BL, Solomon A, et al. Regulation of MMP- 9 production by human corneal epithelial cells[J]. Exp Eye Res, 2001, 73(4): 449-459. 被引量:1
  • 6Gan X, Wong B, Wright SD, et al. Production of matrix metalloproteinase - 9 in CaCO - 2 cells in response to inflammatory stimuli[J]. J Interferom Cytokine Res, 2001, 21 (2) : 93- 98. 被引量:1
  • 7Kouwenhoven M, Carlstrom C, Ozenei V, et al. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke[J]. J Clin Immunol, 2001, 21(5): 365-375. 被引量:1
  • 8Jarrousse F, Boisnic S, Branchet MC, et al. Identification of clustered cells in human hair follicle responsible for MMP - 9 gelatinolytic activity: consequences for the regulation of hair growth[J]. Int J Dermatol, 2001, 40(6) : 385 - 392. 被引量:1
  • 9Vaday GG, Franitza S, Schor H, et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix[ J ]. J Leukoc Biol,2001, 69(6) : 885 - 892. 被引量:1
  • 10Vecil GG, Larsen PH, Corley SM, et al. Interleukin- 1 is a key regulator of matrix metalloproteinase - 9 expression in human neurons in culture and following mouse brain traumain vivo[J]. J Neurosci Res, 2000, 61(2): 212-224. 被引量:1

共引文献74

同被引文献124

  • 1殷忠,李兰荪,张荣庆,刘安恒,栾荣华,王海昌.冠心病患者外周血MMP-9、CRP的变化及其临床意义[J].中国康复医学杂志,2006,21(4):318-321. 被引量:7
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2156
  • 3朱汉东,朱国英,苏晞,宋丹,彭剑,陈国洪.冠心病性别特点和冠状动脉支架术后随访[J].岭南心血管病杂志,2007,13(2):106-108. 被引量:4
  • 4Tew DG, Southan C, Rice SQ, et al. Purification, properties, se- quencing, and cloning of a lipoprotein-associated, serine-depen- dent phospholipase involved in the oxidative modification of low- density lipoproteins[J]. Arterioscler Thromb Vase Biol, 1996,16 (4) :591-599. 被引量:1
  • 5Epps KC, Wilensky RL. Lp-PLA2-a novel risk factor for high-risk coronary and carotid artery disease[J]. J Intern Med,2011,269 (1) :9-106. 被引量:1
  • 6Zalewski A, Macphee C. Role of lipoprotein-associated phospho- lipase A2 in atherosclerosis : biology, epidemiology, and possible therapeutic target [J]. Arterioscler Thromb Vase Biol,2005,25 (5) :923-931. 被引量:1
  • 7Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis[J]. Arterioscler Thromb Vase Biol, 2006,26 ( 11 ) : 2523-2529. 被引量:1
  • 8Six DA, Dennis EA. The expanding superfamily of phospholipase A (2) enzymes:classification and characterization[J]. Biochim Biophys Acta,2000,1488(1/2) : 1-19. 被引量:1
  • 9Serrnys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A (2) inhibitor dara- pladib on human coronary atherosclerotic plaque[J]. Circulation, 2008,118(11 ) : 1172-1182. 被引量:1
  • 10Paik JK, Kim JY, Kim OY, et al. Circulating and PBMC Lp-PLA2 associate differently with oxidative stress and subclinical inflam- mation in nonobese women (menopausal status)[J]. PLos One, 2012,7(2) : e29675. 被引量:1

引证文献12

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部